A tumor-microenvironment-adaptive peptide-based nanophotothermal agent for synergistic photothermal–immunotherapy
Acta Biomaterialia · 2026-08 · 219 · 561-573
DOI: 10.1016/j.actbio.2026.06.029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-08. Verfasst von Hong Ju und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Detection Technology for Tumor Markers, College of Life Science, Linyi University, Shandong 276005, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Peptides, Immunotherapy, Photothermal Therapy. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shandong Province Natural Science Foundation.
Abstract (Originalsprache)
Photothermal therapy (PTT) has attracted considerable attention in cancer treatment due to its noninvasive nature and lack of drug resistance. However, conventional photothermal agents often exhibit poor tumor accumulation, nonspecific thermal damage, and limited monotherapy efficacy, hindering their clinical translation. To overcome these constraints, we developed a tumor-microenvironment-adaptive peptide-based nano-photothermal agent (EIMSeO-IR783) founded on the principle of intermolecular coupling-induced supramolecular photothermal effects, and integrated it with a STING agonist for synergistic photothermal-immunotherapy. The nano-photothermal agent employs a redox-responsive peptide containing selenomethionine residues as a self-assembled skeleton, and realizing the transformation from nanoparticles to nanofibers through redox, thereby regulating the aggregation state of IR783 and inducing the formation of H-aggregates. These H-aggregates enhance non-radiative energy dissipation, leading to improved photothermal conversion efficiency and photostability. In the tumor microenvironment, overexpressed GSH drives adaptive morphological transformation, enabling precise in situ heat generation and improving tumor retention and ablation. Combined with the STING agonist, photothermal-induced immunogenic cell death promotes antigen release, dendritic cell maturation, and T-cell infiltration, eliciting a robust systemic immune response for synergistic photothermal-immunotherapy. This work proposes a tumor-microenvironment-guided strategy for constructing peptide-based photothermal systems, offering a new avenue for precise cancer therapy with controllable photothermal performance and immune synergy. STATEMENT OF SIGNIFICANCE: Photothermal therapy is a promising cancer treatment, but its effectiveness is limited by poor tumor accumulation, nonspecific heating, and insufficient therapeutic outcomes. This study presents a tumor-microenvironment-adaptive peptide-based nanophotothermal agent that undergoes structural transformation in response to intracellular glutathione, enabling localized heat generation and improved tumor retention. The adaptive assembly regulates H-aggregate formation of IR783, enhancing photothermal efficiency and stability. In combination with a STING agonist, the system induces immunogenic tumor cell death and stimulates systemic antitumor immunity, achieving synergistic photothermal-immunotherapy. This work introduces a peptide-guided strategy for controlling photothermal performance within tumors and provides a versatile platform for developing precise and multifunctional biomaterial-based cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory of Detection Technology for Tumor Markers, College of Life Science, Linyi University, Shandong 276005, China.
- Shandong Provincial Key Laboratory of Detection Technology for Tumor Markers, College of Life Science, Linyi University, Shandong 276005, China. Electronic address: dongmxi@126.com.
- Shandong Provincial Key Laboratory of Detection Technology for Tumor Markers, College of Life Science, Linyi University, Shandong 276005, China. Electronic address: songyanqiu@lyu.edu.cn.
- MOE Key Laboratory of Functional Polymer Materials, State Key Laboratory of Medicinal Chemical Biology, Institute of Polymer Chemistry, College of Chemistry, Nankai University, Tianjin 300071, China. Electronic address:…
Förderung
- National Natural Science Foundation of China
- Shandong Province Natural Science Foundation
Zitieren
APA
Ju, H., Han, Z., Chen, T., Xi, D., Song, Y., & Yu, Z. (2026). A tumor-microenvironment-adaptive peptide-based nanophotothermal agent for synergistic photothermal–immunotherapy. Acta Biomaterialia, 219, 561-573. https://doi.org/10.1016/j.actbio.2026.06.029
Vancouver
Ju H, Han Z, Chen T, Xi D, Song Y, Yu Z. A tumor-microenvironment-adaptive peptide-based nanophotothermal agent for synergistic photothermal–immunotherapy. Acta Biomaterialia. 2026;219:561-573. doi:10.1016/j.actbio.2026.06.029
BibTeX
@article{Ju2026,
author = {Ju, Hong and Han, Zhiyu and Chen, Tongtong and Xi, Dongmei and Song, Yanqiu and Yu, Zhilin},
title = {A tumor-microenvironment-adaptive peptide-based nanophotothermal agent for synergistic photothermal–immunotherapy},
journal = {Acta Biomaterialia},
year = {2026},
volume = {219},
pages = {561--573},
doi = {10.1016/j.actbio.2026.06.029}
}
EUVIMED